Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction
Abstract Background Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, myocardial fibrosis, and adverse clinical outcomes....
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2024-11-01
|
| Schriftenreihe: | BMC Cardiovascular Disorders |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12872-024-04364-2 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
